Conformation of the CYP2D6 model substrate sparteine under physiological conditions

Bioorganic & Medicinal Chemistry Letters
1993.0

Abstract

The conformation of the CYP2D6 model substrate sparteine (1) is investigated by NMR techniques over a wide pH range. Regioselectively deuterated analogues are used to aid assignments. At pH > 6, i.e. under physiological conditions, 1 adopts an all-chair conformation (mono-protonated cage structure). Below pH 4, ring C is inverted to a boat conformation, allowing for double protonation at both nitrogens of 1.

Knowledge Graph

Similar Paper

Conformation of the CYP2D6 model substrate sparteine under physiological conditions
Bioorganic & Medicinal Chemistry Letters 1993.0
New 2-oxosparteine derivatives: Synthesis and spectroscopic characterization
Journal of Molecular Structure 2011.0
Homology Modeling of Rat and Human Cytochrome P450 2D (CYP2D) Isoforms and Computational Rationalization of Experimental Ligand-Binding Specificities
Journal of Medicinal Chemistry 2003.0
Synthesis and structure of (+)-2-thionosparteine, a new thioanalogue of lupanine
Journal of Molecular Structure 1999.0
Synthesis and Conformational Analysis of New 17-Alkyl Derivatives of Lupanine and Their Perchlorate Salts
Collection of Czechoslovak Chemical Communications 2004.0
Structural Studies of Norditerpenoid Alkaloids: Conformation Analysis in Crystal and in Solution States
European Journal of Organic Chemistry 2021.0
A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series
Bioorganic & Medicinal Chemistry Letters 2005.0
Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series
Journal of Medicinal Chemistry 1990.0
Solution forms of bouvardin and relatives from NMR studies. 6-O-Methylbouvardin
Journal of the American Chemical Society 1983.0
Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine
Journal of Medicinal Chemistry 1980.0